Urethral Resistive Index (URI): A New Parameter for Diagnosing Urethral Obstruction

This methodological study is designed as a prospective, cross-sectional, and observational diagnostic accuracy study. The primary objective is to evaluate the clinical validity of the Urethral Resistive Index (URI), a novel non-invasive parameter, in the diagnosis of urethral stricture.

Study Population and Groups:

The study will include a total of 60 male participants aged between 18 and 80 years.

Stricture Group (n=30): Patients planned for surgery (urethroplasty or internal urethrotomy) due to suspected urethral stricture, where the presence of the stricture is confirmed intraoperatively.

Control Group (n=30): Healthy male volunteers without lower urinary tract symptoms, matched for age.

Methodology: The study focuses on comparing standard uroflowmetry with "forced" uroflowmetry using the Valsalva maneuver. All clinical and uroflowmetric parameters will be collected at the Ankara Bilkent City Hospital Urology Clinic.

Natural Uroflowmetry: Participants will perform a standard uroflowmetry test. Forced Uroflowmetry: After reaching sufficient bladder fullness again, participants will perform a second test using the Valsalva maneuver (forced voiding).

Calculation: The URI will be calculated using the formula:

URI= Qmax,forced/ Qmax,normal

Statistical Analysis: The diagnostic performance of the URI will be evaluated using Receiver Operating Characteristic (ROC) curve analysis. The Area Under the Curve (AUC) will be calculated, and the optimal cut-off value for determining urethral stricture will be identified with corresponding sensitivity and specificity values. Correlation between URI and clinical symptom scores, such as the International Prostate Symptom Score (IPSS), will also be analyzed.

Inclusion criteria

• Male participants aged between 18 and 80 years.
• For the Stricture Group: Patients scheduled for surgery (urethroplasty or internal urethrotomy) due to suspected urethral stricture, where the diagnosis is confirmed intraoperatively.
• For the Control Group: Healthy male volunteers without any lower urinary tract symptoms.
• Voluntary signing of the Informed Consent Form.

Exclusion criteria

• Voiding volume less than 150 mL.
• Causes of obstruction other than stricture, such as Benign Prostatic Hyperplasia (BPH).
• Diagnosis of neurogenic bladder dysfunction or a history of neurological disease affecting bladder function.
• Presence of severe comorbidities.